id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-259395-ytj21cit	Hoyo, Javier Del	Implementing Telemedicine in Inflammatory Bowel Disease: is COVID-19 the definitive trigger?	2020-05-15		.txt	text/plain	1093	60	45	the pandemic, we already lived times of overwhelmed consultations with financial constraints, and the promise of telemedicine for improving access to better health services at lower costs drew attention to its use. Moreover, the efficacy of telemedicine on health outcomes is inconsistent across different programs used in inflammatory bowel disease (IBD), and their value is difficult to establish when only few economic data are available. In a previous pilot trial, TECCU showed to be a safe strategy to improve health outcomes of complex IBD patients [3] , with a high probability of being more cost-effective in the short term compared to standard care and telephone care [4] . Maybe the pandemic has reduced reluctance amongst physicians to use telemedicine, but funders, policy-makers, providers and patients need to align their interests to implement remote healthcare successfully. In spite of the use of telephone and e-mail in many centers, the development of mature telemedicine programs integrated with electronic health records requires further collaborative efforts between different investigators.	./cache/cord-259395-ytj21cit.txt	./txt/cord-259395-ytj21cit.txt